Literature DB >> 11592852

Expression and activation of matrix metalloproteinase-2 and -9 in rat brain after transient focal cerebral ischemia.

A M Planas1, S Solé, C Justicia.   

Abstract

Matrix metalloproteinases (MMPs) degrade the extracellular matrix and carry out key functions during development and after injury. By means of zymography, Western blot and immunohistochemistry, we studied MMP-2 (gelatinase A) and MMP-9 (gelatinase B) in rat brain after focal cerebral ischemia. The control rat brain showed constitutive MMP-2 and, to a lesser extent, MMP-9, which were mainly present as prozymogens. MMP-2 protein was located in the cell body of neurons, glia, and endothelium, whereas MMP-9 was associated to neurons and myelinated fibre tracts. Ischemia greatly increased MMP activation in two temporal waves, in the first one, MMP-9 protein was induced from 4 h to 4 days, and also a small and short-lasting increase in MMP-2 was detected at 4 h. The second wave showed a massive increase in MMP-2 protein expression and activation by day 4, which was compatible with abundant MMP-2 in reactive microglia/macrophages. Our results are compatible with progressive induction of MMP-9 proform, likely in neurons, shortly after ischemia. For MMP-2, the results suggest a discrete production immediately after reperfusion, while a very enhanced expression and activation of MMP-2 attributable to microglia/macrophages occurs on day 4, and it might contribute to the phagocytic action of these reactive cells. Copyright 2001 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11592852     DOI: 10.1006/nbdi.2001.0435

Source DB:  PubMed          Journal:  Neurobiol Dis        ISSN: 0969-9961            Impact factor:   5.996


  74 in total

1.  Validation of in vivo magnetic resonance imaging blood-brain barrier permeability measurements by comparison with gold standard histology.

Authors:  Angelika Hoffmann; Jörg Bredno; Michael F Wendland; Nikita Derugin; Jason Hom; Tibor Schuster; Hua Su; Peter T Ohara; William L Young; Max Wintermark
Journal:  Stroke       Date:  2011-06-02       Impact factor: 7.914

Review 2.  Hemorrhagic Transformation after Tissue Plasminogen Activator Reperfusion Therapy for Ischemic Stroke: Mechanisms, Models, and Biomarkers.

Authors:  Wei Wang; Mingchang Li; Qianxue Chen; Jian Wang
Journal:  Mol Neurobiol       Date:  2014-11-04       Impact factor: 5.590

Review 3.  The Role of Proteases in Hippocampal Synaptic Plasticity: Putting Together Small Pieces of a Complex Puzzle.

Authors:  Ivan L Salazar; Margarida V Caldeira; Michele Curcio; Carlos B Duarte
Journal:  Neurochem Res       Date:  2015-11-07       Impact factor: 3.996

4.  Matrix metalloproteinase-9 and cell division in neuroblastoma cells and bone marrow macrophages.

Authors:  M Gloria Sans-Fons; Sonia Sole; Coral Sanfeliu; Anna M Planas
Journal:  Am J Pathol       Date:  2010-10-22       Impact factor: 4.307

5.  Peak in matrix metaloproteinases-2 levels observed during recovery from olfactory nerve injury.

Authors:  Richard M Costanzo; Lisa A Perrino
Journal:  Neuroreport       Date:  2008-02-12       Impact factor: 1.837

6.  Effects of hyperbaric oxygen on the expression of claudins after cerebral ischemia-reperfusion in rats.

Authors:  Hong Zhao; Qianru Zhang; Yixue Xue; Xuexin Chen; Randy S Haun
Journal:  Exp Brain Res       Date:  2011-05-31       Impact factor: 1.972

7.  Phenotypic Screening To Discover Novel Chemical Series as Efficient Antihemorrhagic Agents.

Authors:  Irene de Miguel; Josune Orbe; Juan A Sánchez-Arias; José A Rodríguez; Agustina Salicio; Obdulia Rabal; Miriam Belzunce; Elena Sáez; Musheng Xu; Wei Wu; Haizhong Tan; Hongyu Ma; José A Páramo; Julen Oyarzabal
Journal:  ACS Med Chem Lett       Date:  2018-04-16       Impact factor: 4.345

Review 8.  Phytochemicals in Ischemic Stroke.

Authors:  Joonki Kim; David Yang-Wei Fann; Raymond Chee Seong Seet; Dong-Gyu Jo; Mark P Mattson; Thiruma V Arumugam
Journal:  Neuromolecular Med       Date:  2016-05-18       Impact factor: 3.843

9.  Course of matrix metalloproteinase-9 isoforms after the administration of uric acid in patients with acute stroke: a proof-of-concept study.

Authors:  Sergio Amaro; Víctor Obach; Alvaro Cervera; Xabier Urra; Manuel Gómez-Choco; Anna M Planas; Angel Chamorro
Journal:  J Neurol       Date:  2009-04-27       Impact factor: 4.849

10.  Mmp-9, a potential target for cerebral ischemic treatment.

Authors:  Xue Dong; Yu-Ning Song; Wei-Guo Liu; Xiu-Li Guo
Journal:  Curr Neuropharmacol       Date:  2009-12       Impact factor: 7.363

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.